Propanc Biopharma (PPCB) Return on Equity (ROE) (2011 - 2025)
Propanc Biopharma (PPCB) Return on Equity (ROE) from Dec 31, 2011 to Dec 31, 2025. The TTM Propanc Biopharma (PPCB) Return on Equity (ROE) is -29.58%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Propanc Biopharma (PPCB)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2025 | -423.58% | -979.74% |
| 2024 | 48.15% | -43.53% |
| 2023 | 85.26% | -3.21% |
| 2022 | 88.08% | +33.20% |
| 2021 | 66.12% | -49.22% |
| 2020 | 130.22% | -2.79% |
| 2019 | 133.95% | +28.44% |
| 2018 | 104.30% | -27.91% |
| 2017 | 144.67% | -60.49% |
| 2016 | 366.15% | +227.49% |
| 2015 | 111.80% | +89.93% |
| 2014 | 58.87% | -67.71% |
| 2013 | 182.28% | -91.39% |
| 2012 | 2116.67% | -10447.05% |
| 2011 | -20.46% | -104.63% |
| 2010 | 442.11% | +311.96% |
| 2009 | 107.32% | N/A |